Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
SFX-01 by Stalicla for Autism Spectrum Disorder (ASD): Likelihood of Approval
SFX-01 is under clinical development by Stalicla and currently in Phase I for Autism Spectrum Disorder (ASD). According to GlobalData,...